neuroClues sits in the clinical neurodiagnostics infrastructure segment, using eye-tracking biomarkers to support neurological assessment and monitoring. Its positioning is differentiated by translating oculomotor measurement into a CE-marked clinician-facing tool for Parkinsonian and broader neurological disorders.